HEALTH CARE:
BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS
Neptune Technologies & Bioressources, Inc. engages in the research, development, and commercialization of novel extraction technologies and biological therapeutic agents for highly prevalent chronic conditions. It offers Neptune Krill Oil (NKO), a marine oil that provides natural blend of nutritional elements; Neptune Krill Aquatein, a marine protein concentrate that contain amino acids; and OPA3 for the functional food and biopharmaceutical markets. The company's NKO product prevents skin damages caused by chronic exposure to UV rays, reduces the physical and emotional symptoms associated with premenstrual syndrome, and provides relief from dysmenorrheal. It serves nutraceutical, pharmaceutical, nutrigenomics, and cosmetic industries. The company operates in the United States, Europe, and Asia. Neptune Technologies was founded in 1925 and is headquartered in Laval, Canada.
| Market Cap | 282.965 Million | Shares Outstanding | 95.062 Million | Avg 30-day Volume | 1.401 Million |
| P/E Ratio | Dividend Yield | EPS | -0.4 | ||
| Price/Sales | 14.13 | Price cash flow ratio | Price free cash flow ratio | -7.7 | |
| Book Value | 1.06 | Price to Tangible Book | 7.85 | Alpha | 0.02 |
| Short Interest Ratio | % Short Interest to Float | R-squared | 0.273952 | ||
| BETA | 2.72359 | 52-week High/Low | 6.57 / 0.96 | Stddev | 0.22245 |
| Neptune Wellness Solutions Inc Chart by YCharts | |
| Yahoo! Finance | finviz |
| SEC Web Site | SEC DEF 14A Filings |
Please sign in first
none
none
none
| Insider Name | Type | Last Reported Shares Held | Last Reported Date | Filings in past year |
|---|---|---|---|---|
|
6,212,645 | 2012-11-09 | 0 |
| Reporting Owners | Transaction Date | Transaction Code | Shares | Share Price | Acquired or Disposed | Shares Owned Following Transaction | Combined shares owned after filing | Direct/Indirect Ownership | 10b-5 |
|---|---|---|---|---|---|---|---|---|---|
| No current insider transactions | |||||||||
